| Ytd | -19.31% | |
| 1y | -39.41% |
| Open | 33.27 | Prev Close | 32.73 | Low | 32.63 | High | 33.92 | Mkt Cap | 986.38M |
| Vol | 294.21K | Avg Vol | 496.13K | EPS | 1.77 | P/E | 18.51 | Forward P/E | 7.18 |
| Beta | 0.92 | Short Ratio | 4.37 | Inst. Own | 116.11% | Dividend | 0.80 | Div Yield | 2.23 |
| Ex Div Date | 09-15 | Earning | 04-29 | 50-d Avg | 35.62 | 200-d Avg | 40.59 | 1yr Est | 39.60 |
B of A Securities analyst Travis Steed downgrades Conmed (NYSE:CNMD) from Neutral to Underperform
CONMED Corporation (NYSE:CNMD) today announced the appointment of John E. Gallagher as Chief Financi